Search

M. Franco G. Salvoza

Examiner (ID: 10957, Phone: (571)272-4468 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1648, 1671, 1672
Total Applications
807
Issued Applications
458
Pending Applications
116
Abandoned Applications
250

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18726349 [patent_doc_number] => 20230340626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => A "LINE ELIMINATION" LATERAL FLOW IMMUNOCHROMATOGRAPHIC STRIP AND ITS APPLICATION IN CRISPR NUCLEIC ACID DETECTION [patent_app_type] => utility [patent_app_number] => 18/009975 [patent_app_country] => US [patent_app_date] => 2021-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009975 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009975
A "LINE ELIMINATION" LATERAL FLOW IMMUNOCHROMATOGRAPHIC STRIP AND ITS APPLICATION IN CRISPR NUCLEIC ACID DETECTION Jun 9, 2021 Pending
Array ( [id] => 18511380 [patent_doc_number] => 20230227526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => ENGINEERED T CELL RECEPTORS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/001185 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -82 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001185 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001185
ENGINEERED T CELL RECEPTORS AND METHODS OF USE Jun 7, 2021 Pending
Array ( [id] => 20106987 [patent_doc_number] => 12357685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-15 [patent_title] => Vaccine composition for preventing rabies, and preparation method thereof [patent_app_type] => utility [patent_app_number] => 17/333052 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 1248 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333052 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/333052
Vaccine composition for preventing rabies, and preparation method thereof May 27, 2021 Issued
Array ( [id] => 18496190 [patent_doc_number] => 20230218745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE [patent_app_type] => utility [patent_app_number] => 18/000772 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000772 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000772
MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE May 27, 2021 Pending
Array ( [id] => 20897254 [patent_doc_number] => 12704516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-08-11 [patent_title] => Methods and compositions for rapid direct detection and differentiation of infectious from noninfectious virus [patent_app_type] => utility [patent_app_number] => 17/926474 [patent_app_country] => US [patent_app_date] => 2021-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 47 [patent_no_of_words] => 9065 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926474 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926474
METHODS AND COMPOSITIONS FOR RAPID DIRECT DETECTION AND DIFFERENTIATION OF INFECTIOUS FROM NONINFECTIOUS VIRUS May 18, 2021 Pending
Array ( [id] => 18420130 [patent_doc_number] => 20230174591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => Use of Human Resistin as a Trimerization Partner for Expression of Trimeric Proteins [patent_app_type] => utility [patent_app_number] => 17/999071 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12874 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999071 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999071
Use of Human Resistin as a Trimerization Partner for Expression of Trimeric Proteins May 17, 2021 Pending
Array ( [id] => 18675087 [patent_doc_number] => 20230312659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => MRNA OR MRNA COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/926444 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926444 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926444
MRNA OR MRNA COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF May 13, 2021 Abandoned
Array ( [id] => 18449640 [patent_doc_number] => 20230190916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION [patent_app_type] => utility [patent_app_number] => 17/925179 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925179 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925179
COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION May 13, 2021 Pending
Array ( [id] => 17097221 [patent_doc_number] => 20210285012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY [patent_app_type] => utility [patent_app_number] => 17/319564 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30186 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319564
METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY May 12, 2021 Abandoned
Array ( [id] => 18004980 [patent_doc_number] => 20220363746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY [patent_app_type] => utility [patent_app_number] => 17/306884 [patent_app_country] => US [patent_app_date] => 2021-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -84 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306884 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/306884
METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY May 2, 2021 Pending
Array ( [id] => 17022302 [patent_doc_number] => 20210246173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN [patent_app_type] => utility [patent_app_number] => 17/244106 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244106 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/244106
MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN Apr 28, 2021 Abandoned
Array ( [id] => 17185560 [patent_doc_number] => 20210332445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => VIRUS DETECTION PIPELINE [patent_app_type] => utility [patent_app_number] => 17/238466 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238466 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/238466
VIRUS DETECTION PIPELINE Apr 22, 2021 Pending
Array ( [id] => 18483677 [patent_doc_number] => 20230210979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED DESIGNS AND USES [patent_app_type] => utility [patent_app_number] => 17/996727 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996727
ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED DESIGNS AND USES Apr 19, 2021 Pending
Array ( [id] => 19423828 [patent_doc_number] => 12083219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => Methods and compositions for the preparation of aerosols [patent_app_type] => utility [patent_app_number] => 17/233621 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27185 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233621 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/233621
Methods and compositions for the preparation of aerosols Apr 18, 2021 Issued
Array ( [id] => 18374457 [patent_doc_number] => 20230149536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/919224 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -127 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919224 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/919224
COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS INFECTIONS Apr 18, 2021 Pending
Array ( [id] => 17126534 [patent_doc_number] => 20210301303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => ADENOVECTORS FOR DELIVERY OF THERAPEUTIC GENETIC MATERIAL INTO T CELLS [patent_app_type] => utility [patent_app_number] => 17/229098 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229098 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/229098
ADENOVECTORS FOR DELIVERY OF THERAPEUTIC GENETIC MATERIAL INTO T CELLS Apr 12, 2021 Abandoned
Array ( [id] => 18449643 [patent_doc_number] => 20230190919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/996119 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996119 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996119
CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE Apr 12, 2021 Pending
Array ( [id] => 17198658 [patent_doc_number] => 20210338752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => ADENO-ASSOCIATED VIRUS PURIFICATION METHODS [patent_app_type] => utility [patent_app_number] => 17/227527 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227527 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227527
Adeno-associated virus purification methods Apr 11, 2021 Issued
Array ( [id] => 18453269 [patent_doc_number] => 20230194549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT [patent_app_type] => utility [patent_app_number] => 17/918184 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918184 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918184
METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT Apr 7, 2021 Pending
Array ( [id] => 18923445 [patent_doc_number] => 20240026449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => RNA MARKERS FOR DIAGNOSING INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/916577 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916577 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916577
RNA MARKERS FOR DIAGNOSING INFECTIONS Apr 7, 2021 Pending
Menu